Bettina Ryll
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Sieving for gold: external comparator studies to prioritize drugs for late-stage clinical trial.
Journal: Journal of comparative effectiveness research
Published: February 04, 2026
Policies to promote affordability and access across the life cycle of costly new drugs.
Journal: BMJ (Clinical research ed.)
Published: November 11, 2025
Uveal melanoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.
Journal: ESMO open
Published: September 24, 2025
ESMO basic requirements for AI-based biomarkers in oncology (EBAI).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 16, 2025
Messages for ultraviolet-radiation protection to fair-skinned populations.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 28, 2025
Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop.
Journal: The Lancet. Oncology
Published: February 19, 2025
Scaling up the impact of melanoma advocacy: an interview with Bettina Ryll.
Journal: Disease models & mechanisms
Published: December 24, 2024
Editorial: Towards continued and affordable accessibility of innovative drugs: sustainable development and efficient use of medicines.
Journal: Frontiers in pharmacology
Published: September 03, 2024
Survival is not enough: understanding the mental burden of cutaneous melanoma.
Journal: The British journal of dermatology
Published: January 29, 2024
The evolving landscape of tissue-agnostic therapies in precision oncology.
Journal: CA: a cancer journal for clinicians
Published: January 20, 2024
PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe.
Journal: Acta oncologica (Stockholm, Sweden)
Published: December 22, 2023
Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group.
Journal: International journal of technology assessment in health care
Published: June 16, 2023
Last Updated: 09/26/2026